Regulatory and Washington

WOONSOCKET, R.I. — CVS Health on Thursday announced that current EVP and general counsel Thomas M. Moriarty has been appointed to the newly created role of chief policy and external affairs officer.

This week, the Senate Judiciary Committee considered the nomination of Judge Neil Gorsuch to the United States Supreme Court. Since vacancies on the bench are rare and the political stakes so high, few spectacles in Washington D.C. invite this level of drama. He was confirmed by the committee but when his nomination eventually goes to the floor of the Senate for a vote, the real fun will begin. (See “nuclear option.”) Lost in the hype is what his eventual seat on the court will mean to retail operators.

ALEXANDRIA, Va. — All told, as many as 118 healthcare organizations have signed letters supporting legislation that would prohibit retroactive pharmacy direct and indirect remuneration (DIR) fees in the Medicare Part D program.

The support is up significantly from last year, when more than 95 health care organizations signaled their support in similar letters to the House and Senate last September.

OLYMPIA, Wash. — The retail pharmacy industry is pursuing legal action against Washington state over a “substantively and procedurally flawed” rule  that would pay pharmacies below the actual cost to dispense Medicaid prescriptions.

The National Association of Chain Drug Stores joined the Washington State Pharmacy Association and the National Community Pharmacists Association in preventing a rule that would jeopardize patient access to their medications, the associations said.

WASHINGTON — Retailers may soon have a voice when it comes to disclosing surcharges related to card payments.

The Supreme Court ruled on Wednesday, March 29, that First Amendment free speech rights should be considered when determining how merchants disclose to their shoppers that credit card swipe fees can drive up the price of merchandise.

WASHINGTON — The Natural Products Association last week hosted its members from across the nation for its 20th Annual Natural Products Day in the nation's capital.  NPD attendees, which included retailers, suppliers, distributors and other industry consultant members, met with more than 100 members of Congress and staff to educate them on the industry’s issues and natural products’ roles in preventive health care and overall wellness.

WASHINGTON — President Donald Trump’s choice to lead the Food and Drug Administration hopes to lower drug costs by approving cheaper generic drugs more quickly.

According to Bloomberg, former FDA Deputy Commissioner Scott Gottlieb would make streamlining drug approvals his top priority, with a particular focus on complex medications that combine old drugs with newer delivery devices, as well as ones with unusually complicated formulations. The news outlet added such changes in approach could come without Congressional approval.

SAN FRANCISCO — The American Pharmacists Association Annual Meeting and Exposition drew more than 6,100 pharmacists and student pharmacists form March 24-27 in San Francisco.

This year’s theme, “Making an Impact in Patient Care,” served as a mandate for attendees to step up efforts in patient care and demonstrate why pharmacists should have a much larger role in any new federal health care policy.